Arq Neuropsiquiatr 2007;65(3-B):830-833 Dementia Pugilistica with CliniCal Features oF alzheimer’s Disease

A 61-year-old ex-boxer presented with a three-year history of progressive memory decline. During a seven-year follow-up period, there was a continuous cognitive decline, very similar to that usually observed in Alzheimer’s disease. Parkinsonian, pyramidal or cerebellar signs were conspicuously absent. Neuropathological examination revealed the typical features of dementia pugilistica: cavum septi pellucidi with multiple fenestrations, numerous neurofibrillary tangles in the cerebral isocortex and hippocampus (and rare senile plaques). Immunohistochemistry disclosed a high number of tau protein deposits and scarce beta-amyloid staining. this case shows that dementia pugilistica may present with clinical features practically undistinguishable from Alzheimer’s disease. Key worDs: dementia, dementia pugilistica, punch drunk, Alzheimer’s disease, chronic traumatic encephalopathy, parkinsonian/motor signs, neuropathology. Dementia pugilistica com características clínicas de doença de alzheimer resumo um ex-boxeador de 61 anos apresentou-se com história de três anos de perda progressiva de memória e evoluiu com declínio cognitivo lentamente progressivo, sugestivo de doença de Alzheimer, durante seguimento de sete anos. sinais parkinsonianos, piramidais ou cerebelares estiveram ausentes durante toda a evolução. exame neuropatológico evidenciou características típicas de dementia pugilistica: cavum do septo pelúcido com múltiplas fenestrações, numerosos emaranhados neurofibrilares no isocórtex cerebral e hipocampo (e raras placas senis). Imuno-histoquímica confirmou número elevado de depósitos de proteína tau e raros de beta-amilóide. este caso demonstra que dementia pugilistica pode apresentar quadro clínico indistinguível daquele da doença de Alzheimer. PAlAvrAs-chAve: demência, dementia pugilistica, síndrome punch-drunk, doença de Alzheimer, encefalopatia traumática crônica, sinais motores/parkinsonianos, neuropatologia. Behavioral and cognitive Neurology unit, Department of Neurology, university of são Paulo school of medicine, são Paulo sP, Brazil; Department of Pathology, university of são Paulo school of medicine, são Paulo sP, Brazil; ludwig Institute for cancer research, sao Paulo Branch, sao Paulo sP, Brazil. received 18 January 2007, received in final form 8 may 2007. Accepted 15 June 2007. Dra. Renata Areza-Fegyveres Rua Oscar Freire 1702 / 44 05409-011 São Paulo SP Brasil. E-mail: [email protected] martland, in 1928, first brought the expression “punch drunk syndrome” to medical literature, hitherto used by the lay public and boxing fans to name the condition that some boxers develop during or after their fighting career. the syndrome consisted of extrapyramidal and cerebellar signs and symptoms, associated or not, with cognitive and behavioral abnormalities. In 1937, the designation “dementia pugilistica” was proposed. critchley, in 1957, named it “chronic progressive encephalopathy of the boxer”, being more descriptive in that it represents the long term cumulative effect of repetitive head trauma. however, the label dementia pugilistica has been more frequently used. we report the clinical and neuropathological findings of a case of dementia pugilistica presenting a cognitive profile similar to Alzheimer’s disease (AD). Informed consent to publish these data was given by the patient’s wife and son. Case the patient was a 61 year-old former boxer with six years of education, who presented with a three-year history of memory decline in which he kept forgetting recent events, names of known relatives and where he had left objects. the memory disturbance was followed by spatial disorientation in surroundings. he began amateur boxing at the age of 16 and had fought for 14 years as an amateur, and three years as a professional boxer in the “fly-weight” category. he fought more than 60 bouts, including southAmerican and international competitions and won the majority of his contests. he lost 4 fights on points, but had never been knocked-out. he was a heavy smoker, and had undergone gastric surgery forty years earlier. Also, he had Arq Neuropsiquiatr 2007;65(3-B) 831 no history of psychiatric disturbances, alcoholism or drug abuse and no family history of dementia. General physical examination revealed no abnormalities. on neurological examination, he scored 24 points in the mini-mental state examination. muscle power, sensory system, cranial nerves, equilibrium, kinesis, muscle tonus, coordination, deep tendon and superficial reflexes were all normal. Neuropsychological evaluation showed predominant memory impairment. the total score on the mattis Dementia rating scale (mattis Drs) was 104 points out of 144, with greater impairment in the memory subscale. A thorough laboratory investigation including cerebrospinal fluid analysis was unremarkable. Apolipoprotein ε allele polymorphism detected the ε3/ε3 genotype. computed tomography (ct) scans revealed enlargement of the 3 and lateral ventricles, cortico-subcortical atrophy and presence of cavum septi pellucidi. magnetic resonance imaging studies confirmed the ct findings. single photon emission computed tomography showed mild hypoperfusion of the frontal lobes bilaterally. this patient was followed with at least two medical evaluations a year for seven years. No cerebellar, pyramidal or extrapyramidal signs were seen during the follow-up period. his cognitive impairment steadily worsened. During the follow-up, the mattis Drs total score decreased to 101 after six months, falling to 86 points after four years. with progression of the disease, predominant impairment in memory, attention and executive functions were confirmed by poor performance in memory subtests from the wechsler memory scale, the visual retention test: multiple choice, the Block Design (wechsler Adult Intelligence scale wAIs), the hooper visual organization test, the trail making test, the maze test and the category fluency test (animals per minute). rivastigmine was prescribed for approximately one year and gradually titrated to 6 mg BID with dubious results. Death occurred seven years after the first consultation and was caused by gastric adenocarcinoma. macroscopic examination of the brain at autopsy showed moderate and symmetric atrophy, particularly of the frontal and temporal lobes, along with moderate enlargement of the lateral ventricles, especially at the level of the inferior horns. Presence of total cavum septi pellucidi, and a very thin septum with multiple fenestrations across almost its full extension was evident (Fig 1). slices were taken from the cingulate gyrus, frontal, parietal, temporal, and occipital cortices, hippocampus, lenticular nucleus, thalamus, amygdala, midbrain, pons, medulla, cerebellar cortex, and dentate nucleus. All fragments were stained with h&e, Bielschowsky and Nissl stains, and weil method for myelin. Immunohistochemistry was performed with the GFAP antibodies (Dako A/s, Denmark, m0761, clone 6F2, monoclonal mouse anti human glial fibrillary acidic protein); ubiquitin (Dako A/s, Denmark, Z0458, polyclonal Ab-rabbit anti-human ubiquitin); beta-amiloid (Dako A/s, Denmark, m0872, clone 6F/3D, monoclonal mouse Abresidue 8-17); tau protein (Dako A/s, Denmark, A0024, polyclonal tau-P); GsK3 beta (chemicon International Inc., usA, AB8687, polyclonal rabbit anti glycogen synthase kinase 3 beta); and alpha-synuclein (chemicon International Inc., usA, AB5038, polyclonal rabbit anti synuclein alpha); using hydrolytic microwave antigenic retrieval and detection with peroxidase Ab-Dako envision labelled Polymer (Dako corporation, usA). microscopic examination on h&e stain showed mild to moderate neuronal loss and reactive gliosis in all isocortical structures, predominantly at the frontal and temporal lobes. Intense neuronal loss with reactive gliosis at the cA1 sector was evident, along with less intense loss in the cA4 sector of the hippocampus. Basal ganglia, thalami, brain stem and cerebellum were unremarkable, except for the presence of neurofibrillary degeneration of some neuFig 1. Macroscopic analysis: coronal slice showing the cavum of septi pellucidi. 832 Arq Neuropsiquiatr 2007;65(3-B) Fig 2. Imunohistochemistry of frontal cortex: neurofibrillary tangles. Bielschowsky method X 400. Fig 3. Imunohistochemistry of frontal cortex: tau protein deposits: polyclonal antibody X 400. rons of the substantia nigra and locus coeruleus. however, moderate reactive gliosis was detected at the putamen and thalamus on GFAP stain. status spongiosus was absent. Neurofibrillary tangles detected through Bielschowsky (Fig 2) and tau protein stains (Fig 3) were present in large amounts (5 to 6 per high power field-hPF) at the cA4, cA1 sectors of the hippocampus, at the pre-subicullum, subicullum and entorhinal cortex. they were present in moderate amounts (1 to 3 per hPF) at the frontal, cingulate, temporal and parietal cortices, and absent at the occipital cortex. rare beta-amyloid senile plaques were found only at the subicullum and entorhinal cortex. thread-like deposits were absent in all structures. Granulo-vacuolar degeneration was not detected. GsK3 beta and alpha synuclein stains gave negative results.